Equities
  • Price (EUR)45.83
  • Today's Change0.78 / 1.73%
  • Shares traded447.00
  • 1 Year change15.15%
  • Beta1.0193
Data delayed at least 15 minutes, as of Aug 11 2020 18:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

  • Revenue in USD (TTM)153.59bn
  • Net income in USD-4.16bn
  • Incorporated1979
  • Employees49.50k
  • Location
    Cardinal Health Inc7000 Cardinal PlDUBLIN 43017-1091United StatesUSA
  • Phone+1 (614) 757-3033
  • Fax+1 (614) 757-6000
  • Websitehttps://www.cardinalhealth.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.